^
BIOMARKER:

Chr rearrangement(11)(q23)

News
Twitter
Trials
Chr rearrangement(11)(q23)
AML
cytarabine / daunorubicin liposomal formulation
Resistant: C3 – Early Trials
Chr rearrangement(11)(q23)
AML
cytarabine
Resistant: C3 – Early Trials